Peptide Stability
Peptide stability encompasses degradation pathways, aggregation mechanisms, and storage strategies that determine peptide shelf life and biological activity.
Peptide Stability
Peptide stability determines how long a peptide maintains its structure and function during storage and use. Understanding degradation pathways enables proper storage conditions and formulation strategies to maximize peptide utility.
Major Degradation Pathways
Oxidation
Methionine and cysteine residues are particularly susceptible to oxidation. Methionine is converted to methionine sulfoxide, and cysteine can form disulfide bonds or sulfenic acid. Oxidation is accelerated by:
- Dissolved oxygen in solutions
- Transition metal ions (copper, iron)
- Light exposure
- Elevated pH
Histidine and tryptophan also undergo oxidation under harsh conditions. The presence of even trace metals dramatically increases oxidation rates.
Deamidation
Asparagine and glutamine residues undergo spontaneous deamidation to aspartate and glutamate respectively. This converts a neutral residue to a negatively charged one, potentially disrupting structure and activity.
The mechanism proceeds through a succinimide intermediate. Asparagine deamidation is faster than glutamine and depends on:
- Flanking residues (Gly, Ser, Thr at the C-terminal side accelerate deamidation)
- pH (faster at alkaline pH)
- Temperature
- Sequence context (Asn-Gly sequences are particularly labile)
Hydrolysis
Peptide bonds can hydrolyze, though this is generally slow under mild conditions. Acidic pH accelerates aspartate-proline bond cleavage. Elevated temperature increases hydrolysis rates for all peptide bonds.
Racemization
L-amino acids can convert to D-isomers under basic conditions or at elevated temperatures. Aspartate residues racemize most rapidly through a beta-elimination mechanism. Racemization destroys biological activity and can generate immunogenic D-amino acid-containing species.
Aggregation
Peptides, especially hydrophobic sequences, tend to aggregate through:
- Hydrophobic interactions: Non-polar regions associate to minimize water contact
- Hydrogen bonding: Intermolecular beta-sheet formation creates amyloid-like structures
- Electrostatic interactions: Oppositely charged peptides associate
- Disulfide formation: Intermolecular crosslinks stabilize aggregates
Aggregation reduces effective concentration and can trigger immune responses in therapeutic applications.
Storage Recommendations
Optimal storage conditions vary by peptide but follow general principles:
Lyophilized Peptides
- Store at -20 degrees Celsius or below for long-term storage
- Desiccant in the container prevents moisture-induced degradation
- Inert atmosphere (nitrogen or argon) reduces oxidation
- Amber glassware protects light-sensitive sequences
Solution Storage
- Aliquot to avoid repeated freeze-thaw cycles
- Use pH 4-5 buffers for maximum stability
- Add antioxidants (ascorbic acid, BHT) for oxidation-prone sequences
- Chelating agents (EDTA) sequester metal ions
Stability by Residue
| Residue | Primary Degradation | Prevention Strategy |
|---|---|---|
| Met | Oxidation | Inert atmosphere, antioxidants |
| Asn | Deamidation | Low temperature, acidic pH |
| Cys | Disulfide formation, oxidation | Inert atmosphere, blocking agents |
| Trp | Oxidation | Amber storage, antioxidants |
| Asp-Pro | Hydrolysis | Avoid acidic conditions |
Mnemonic: DOGMA
Remember key degradation pathways with DOGMA:
- Deamidation of Asn and Gln
- Oxidation of Met and Cys
- General hydrolysis at elevated conditions
- Metal-catalyzed reactions accelerated by trace ions
- Aggregation through hydrophobic and electrostatic forces
Practical Considerations
Always characterize peptide purity by HPLC upon receipt. Record storage conditions and dates. For therapeutic peptides, forced degradation studies under accelerated conditions (elevated temperature, humidity, light) predict shelf life and identify critical quality attributes requiring monitoring.